HomeASTRAZEN • NSE
add
Astrazeneca Pharma India Ltd
Previous close
₹9,111.50
Day range
₹9,040.00 - ₹9,205.50
Year range
₹6,220.00 - ₹10,691.00
Market cap
227.56B INR
Avg Volume
133.76K
P/E ratio
196.98
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 4.80B | 25.39% |
Operating expense | 1.52B | 31.34% |
Net income | 582.50M | 47.55% |
Net profit margin | 12.12 | 17.67% |
Earnings per share | — | — |
EBITDA | 786.78M | 55.87% |
Effective tax rate | 25.77% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.37B | 6.16% |
Total assets | 15.18B | 40.82% |
Total liabilities | 7.48B | 104.25% |
Total equity | 7.70B | — |
Shares outstanding | 25.00M | — |
Price to book | 29.57 | — |
Return on assets | — | — |
Return on capital | 22.85% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 582.50M | 47.55% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1979
Website
Employees
600
